EUVIMEDEUVIMED entdecken
Open Access

Clinical and Genetic Risk Factors Predict Atrial Fibrillation on the Basis of Hypertrophic Cardiomyopathy

Young Shin Lee iD, Pil-Sung Yang iD, Eunsun Jang iD, Daehoon Kim, Hee Tae Yu iD, Tae-Hoon Kim iD, Jae-Sun Uhm iD, Jung-Hoon Sung iD, Hui-Nam Pak iD, Moon-Hyoung Lee iD, Jin-Bae Kim, Boyoung Joung iD

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.124.038074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Young Shin Lee und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology Department of Internal Medicine Kyung Hee University Medical Center Seoul Korea. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cardiomyopathy, Hypertrophic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clinical and genetic predispositions are significant in predicting atrial fibrillation (AF); however, their role in patients with hypertrophic cardiomyopathy (HCM) remains unclear. This study aims to elucidate the impact of clinical and genetic risk factors on the development of AF in patients with and without HCM. Methods and Results This retrospective analysis involved data from the UK Biobank cohort. Participants were divided into 3 groups based on their validated polygenic risk score for AF: the bottom 10% as low risk, the top 10% as high risk, and the rest as intermediate risk. We assessed the incidence of AF and cardiovascular complications and analyzed its predictors, including genetic risk. We examined 1180 patients with HCM (mean age, 61.1±7.1; 63.0% men) and 476 238 participants without HCM (mean age, 57.0±8.1; 45.3% men). During the 11.6‐year follow‐up period, the age‐ and sex‐adjusted AF incidence rates for the low, intermediate, and high genetic risk groups were 2.4, 3.6, and 5.4 per 100 person‐years in participants with HCM and 0.2, 0.5, and 1.0 per 100 person‐years in participants without HCM, respectively. Genetic risk, evaluated as a continuous variable using polygenic risk score, was a less significant predictor of AF in the HCM group (hazard ratio [HR], 1.35 [95% CI, 1.21–1.49]) than in non‐HCM group (HR, 1.57 [95% CI, 1.56–1.59]; P =0.005 for interaction). A high genetic risk was significantly associated with the risk of cardiovascular complications in both groups.

Conclusions

Genetic predisposition is associated with the development of AF and cardiovascular complications in people with and without HCM; this association was weaker in the HCM group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCardiomyopathy, HypertrophicHumansMaleFemaleMiddle AgedRetrospective StudiesIncidenceGenetic Predisposition to DiseaseRisk AssessmentAgedRisk FactorsUnited KingdomMultifactorial Inheritance

Stichwörter der Autor:innen

UK Biobankatrial fibrillationhypertrophic cardiomyopathypolygenic risk score

Autor:innen und Institutionen

  • Division of Cardiology Department of Internal Medicine Kyung Hee University Medical Center Seoul Korea.
  • Department of Cardiology CHA Bundang Medical Center CHA University Seongnam Republic of Korea.
  • Division of Cardiology Department of Internal Medicine Severance Cardiovascular Hospital Yonsei University College of Medicine Seoul Republic of Korea.

ORCID-Profile: Young Shin Lee, Pil-Sung Yang, Eunsun Jang, Hee Tae Yu, Tae-Hoon Kim, Jae-Sun Uhm, Jung-Hoon Sung, Hui-Nam Pak, Moon-Hyoung Lee, Boyoung Joung

Zitieren

APA

Lee, Y. S., Yang, P. S., Jang, E., Kim, D., Yu, H. T., Kim, T. H., Uhm, J. S., Sung, J. H., Pak, H. N., Lee, M. H., Kim, J. B., & Joung, B. (2025). Clinical and Genetic Risk Factors Predict Atrial Fibrillation on the Basis of Hypertrophic Cardiomyopathy. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.038074

Vancouver

Lee YS, Yang PS, Jang E, Kim D, Yu HT, Kim TH, et al. Clinical and Genetic Risk Factors Predict Atrial Fibrillation on the Basis of Hypertrophic Cardiomyopathy. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.038074

BibTeX
@article{Lee2025,
  author = {Lee, Young Shin and Yang, Pil-Sung and Jang, Eunsun and Kim, Daehoon and Yu, Hee Tae and Kim, Tae-Hoon and Uhm, Jae-Sun and Sung, Jung-Hoon and Pak, Hui-Nam and Lee, Moon-Hyoung and Kim, Jin-Bae and Joung, Boyoung},
  title = {Clinical and Genetic Risk Factors Predict Atrial Fibrillation on the Basis of Hypertrophic Cardiomyopathy},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.124.038074}
}
Kostenlos starten →